A SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE

被引:0
|
作者
van Maanen, B. M. [1 ]
Postma, M. J. [1 ]
de Boer, P. T. [1 ]
机构
[1] Univ Groningen, Groningen, Netherlands
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PIN44
引用
收藏
页码:A414 / A414
页数:1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF QUADRIVALENT INFLUENZA VACCINE IN SPAIN
    Garcia Rojas, A.
    Ortiz de Lejarazu, R. L.
    Reina, J.
    Callejo, D.
    Cuervo Uria, J.
    Morano Larragueta, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A588 - A588
  • [2] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [3] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S651 - S651
  • [4] The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
    Kohli, Michele A.
    Maschio, Michael
    Mould-Quevedo, Joaquin F.
    Drummond, Michael
    Weinstein, Milton C.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4603 - 4610
  • [5] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    [J]. VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [6] Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis
    You, Joyce H. S.
    Ming, Wai-Kit
    Chan, Paul K. S.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 564 - 571
  • [7] QUADRIVALENT INFLUENZA VACCINE IN HONG KONG- A COST-EFFECTIVENESS ANALYSIS
    You, J.
    Ming, W.
    Chan, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A678 - A678
  • [8] Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
    Marbaix, Sophie
    Dauby, Nicolas
    Mould-Quevedo, Joaquin
    [J]. EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 608 - 619
  • [9] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [10] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14